Precision therapy guided by genotypic antibiotic resistance for <i>Helicobacter pylori</i> eradication: A prospective, randomized controlled trial
G-AST-guided therapy yielded higher eradication rates than empirical BQT in first-line <i>H. pylori</i> treatment without increasing adverse events, supporting the clinical utility of individualized, resistance-based therapy.
Authors
- Congcong Min (ORCID: https://orcid.org/0000-0002-4752-7649)
- Chao Shi (ORCID: https://orcid.org/0000-0002-5129-207X)
- Yan Xu (ORCID: https://orcid.org/0000-0003-3304-3579)
- Cuiping Ma (ORCID: https://orcid.org/0000-0001-5491-7269)
- Tong Wang (ORCID: https://orcid.org/0000-0002-3542-4829)
- Zibin Tian (ORCID: https://orcid.org/0000-0002-3211-2934)
- Yanan Yu (ORCID: https://orcid.org/0000-0002-7530-1647)
- Tao Mao (ORCID: https://orcid.org/0000-0002-5294-5474)
- Lin Yang (ORCID: https://orcid.org/0000-0003-2212-7478)
- Jingwen Hao (ORCID: https://orcid.org/0000-0003-4904-1412)
Institutions
- Qingdao University (CN)
- Qingdao University of Science and Technology (CN)
- Qingdao Mental Health Center (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.3748/wjg.v31.i42.110717
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00